GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Otsuka Holdings Co Ltd (OTCPK:OTSKY) » Definitions » Debt-to-EBITDA
中文

Otsuka Holdings Co (Otsuka Holdings Co) Debt-to-EBITDA

: -1.32 (As of Dec. 2023)
View and export this data going back to 2012. Start your Free Trial

Debt-to-EBITDA measures a company's ability to pay off its debt.

Otsuka Holdings Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $613 Mil. Otsuka Holdings Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $875 Mil. Otsuka Holdings Co's annualized EBITDA for the quarter that ended in Dec. 2023 was $-1,126 Mil. Otsuka Holdings Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -1.32.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Otsuka Holdings Co's Debt-to-EBITDA or its related term are showing as below:

OTSKY' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.29   Med: 0.93   Max: 1.45
Current: 0.87

During the past 13 years, the highest Debt-to-EBITDA Ratio of Otsuka Holdings Co was 1.45. The lowest was 0.29. And the median was 0.93.

OTSKY's Debt-to-EBITDA is ranked better than
64.85% of 660 companies
in the Drug Manufacturers industry
Industry Median: 1.665 vs OTSKY: 0.87

Otsuka Holdings Co Debt-to-EBITDA Historical Data

The historical data trend for Otsuka Holdings Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Otsuka Holdings Co Annual Data
Trend Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.99 0.80 0.84 0.71 0.87

Otsuka Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 0.46 0.56 0.46 -1.32

Competitive Comparison

For the Drug Manufacturers - General subindustry, Otsuka Holdings Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Otsuka Holdings Co Debt-to-EBITDA Distribution

For the Drug Manufacturers industry and Healthcare sector, Otsuka Holdings Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Otsuka Holdings Co's Debt-to-EBITDA falls into.



Otsuka Holdings Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Otsuka Holdings Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(613.079 + 874.522) / 1715.186
=0.87

Otsuka Holdings Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(613.079 + 874.522) / -1125.672
=-1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Otsuka Holdings Co  (OTCPK:OTSKY) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Otsuka Holdings Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Otsuka Holdings Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Otsuka Holdings Co (Otsuka Holdings Co) Business Description

Traded in Other Exchanges
Address
2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo, JPN, 101-0048
Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.